UCSF

ZINC04468780

Substance Information

In ZINC since Heavy atoms Benign functionality
December 3rd, 2005 30 No

Other Names:

(6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicycl

3-[(acetyloxy)methyl]-7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]am

60846-21-1

63527-52-6

63527-52-6; CTX; Cefotaxim Hikma (TN); Cefotaxime (INN); D07647

63527-53-7

64485-93-4 (mono-hydrochloride salt)

64485-93-4; C08113; Cefotaxime sodium

64485-93-4; CEFOTAXIME SODIUM SALT; CPD001551784; SAM002643511

64485-93-4; Cefotaxime sodium salt; Prestwick_823

64485-93-4; CTX; Cefotaxime sodium (JP16/USP); Claforan (TN); D00919

AC-217

AC1L1E42

AC1L9UKL

AC1NSF5T

AC1NSF6T

AC1NUIF8

AC1NX3QV

AC1NZU9Q

AC1O712I

AC1O7G8N

AC1OC9NB

AKOS003286450

BIDD:GT0681

BPBio1_000240

BRD-K78364995-236-03-5

BRD-K99586414-236-02-3

BSPBio_000218

BSPBio_001961

C06885

C16H17N5O7S2

CE3

cef-

Cefcil

Cefotax

Cefotaxim

Cefotaxim Hikma

Cefotaxim Hikma (TN)

Cefotaxim sodium salt

Cefotaxim sodium salt, Antibiotic for Culture Media Use Only

Cefotaxima

Cefotaxima acid

Cefotaxima [INN-Spanish]

Cefotaxime

Cefotaxime (BAN

Cefotaxime (INN)

Cefotaxime (sodium salt)

Cefotaxime acid

Cefotaxime Sodium

Cefotaxime sodium salt

Cefotaxime sodium salt, 95%

CEFOTAXIME SODIUM; CPD001551784; SAM002643511

CEFOTAXIME SODIUM; [64485-93-4]

Cefotaxime [INN:BAN]

cefotaxime(1-)

Cefotaximum

Cefotaximum [INN-Latin]

Cephotaxim

Cephotaxime

Cffotaxime Sodium [64485-93-4]

CHEBI:112504; CHEBI:41475; CHEBI:3497

CHEBI:204928

CHEMBL102

CID2632

CID456256

CID5361298

CID5361354

CID5479527

CID5742673

CID5916965

CID6540461

CID6604086

CID6914272

CID7566336

CID9868614

Claforan

Claforan (*Sodium salt*)

D07647

DAP000146

DB00493

DivK1c_000767

EINECS 264-299-1

FDA)

HMS2090M11

HR-756

HR-756; RU-24756

IDI1_000767

INN); Cefotaxime Sodium (FDA

INN); Cefotaxime Sodium (JAN

JAN

KBio1_000767

KBio2_000548

KBio2_003116

KBio2_005684

KBio3_001181

KBioGR_000736

KBioSS_000548

Klaforan

LS-149920

LS-187246

MFCD00079073

MolPort-002-339-742

MolPort-005-934-578

MolPort-006-834-754

NCGC00021126-01

NINDS_000767

Prestwick0_000139

Prestwick1_000139

Prestwick2_000139

Prestwick3_000139

Pretor

RU 24662

RU-24756

sodium 3-[(acetyloxy)methyl]-7-{[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]o

SPBio_000138

SPBio_002157

Spectrum2_000119

Spectrum3_000331

Spectrum4_000268

Spectrum5_000667

Spectrum_000108

SS-7557

STK383264

UNII-N2GI8B1GK7

USAN

USP

USP)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.87 6.09 -70.18 3 12 -1 176 454.466 8

Vendor Notes

Note Type Comments Provided By
SOLUBILITY .; H2O: aqueous solutions of pH 4.3-6.2 are stable up to 3 weeks at 2-8 °C.soluble Indofine
APPEARANCE .; white to yellow Indofine
ALOGPS_SOLUBILITY 1.46e-01 g/l DrugBank-approved
M.P 162-163 C Indofine
Purity 97% Fluorochem
Indications Antibiotic KeyOrganics Bioactives
H phrase H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation; H317: May cause an allergic skin reaction Acros Organics
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : MZ-3003; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER; 1 Sodium NIH Clinical Collection via PubChem
UniProt Database Links NORG_STAA8 ChEBI
P phrase P261: Avoid breathing dust/fume/gas/mist/vapors/spray; P304 + P341: IF INHALED: If breathing is difficult, remove to fresh air and keep at rest in a position comfortable for breathing; P342 + P311: If experiencing respiratory symptoms: Call a POISON CENTE Acros Organics
R phrase R36/37/38: Irritating to eyes, respiratory system and skin.; R42/43: May cause sensitisation by inhalation and skin contact. Acros Organics
S phrase S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.; S45: In case of accident or if you feel unwell, seek medical advice immediat Acros Organics
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: MZ-3003; SALT: 1 Sodium; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )